Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;59(4):722-729.
doi: 10.1194/jlr.P080333. Epub 2018 Feb 20.

An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort

Affiliations

An exome-wide sequencing study of lipid response to high-fat meal and fenofibrate in Caucasians from the GOLDN cohort

Xin Geng et al. J Lipid Res. 2018 Apr.

Abstract

Our understanding of genetic influences on the response of lipids to specific interventions is limited. In this study, we sought to elucidate effects of rare genetic variants on lipid response to a high-fat meal challenge and fenofibrate (FFB) therapy in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) cohort using an exome-wide sequencing-based association study. Our results showed that the rare coding variants in ITGA7, SIPA1L2, and CEP72 are significantly associated with fasting LDL cholesterol response to FFB (P = 1.24E-07), triglyceride postprandial area under the increase (AUI) (P = 2.31E-06), and triglyceride postprandial AUI response to FFB (P = 1.88E-06), respectively. We sought to replicate the association for SIPA1L2 in the Heredity and Phenotype Intervention (HAPI) Heart Study, which included a high-fat meal challenge but not FFB treatment. The associated rare variants in GOLDN were not observed in the HAPI Heart study, and thus the gene-based result was not replicated. For functional validation, we found that gene transcript level of SIPA1L2 is associated with triglyceride postprandial AUI (P < 0.05) in GOLDN. Our study suggests unique genetic mechanisms contributing to the lipid response to the high-fat meal challenge and FFB therapy.

Keywords: cholesterol; epidemiology; genetics; high-density lipoprotein; low-density lipoprotein; postprandial lipemia; rare variant; triglyceride; whole-exome sequencing.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Fraction of SNPs with different MAF range within different categories. The categories include synonymous, nonsynonymous, and loss of function (i.e., splicing, stopgain, and stoploss). The y axis indicates the fraction of SNPs with a different MAF range.
Fig. 2.
Fig. 2.
Distribution of residuals for regression of phenotypes on their covariates. The diamonds indicate corresponding residual values of rare variant carriers. The x axis is the Z score for residuals. The y axis is the sample counts.

References

    1. Fodor G. 2010. Primary prevention of CVD: treating dyslipidemia. BMJ Clin. Evid. 2010: 0215. - PMC - PubMed
    1. Arsenault B. J., Boekholdt S. M., and Kastelein J. J.. 2011. Lipid parameters for measuring risk of cardiovascular disease. Nat. Rev. Cardiol. 8: 197–206. - PubMed
    1. Beekman M., Heijmans B. T., Martin N. G., Pedersen N. L., Whitfield J. B., DeFaire U., van Baal G. C. M., Snieder H., Vogler G. P., and Slagboom P. E.. 2002. Heritabilities of apolipoprotein and lipid levels in three countries. Twin Res. 5: 87–97. - PubMed
    1. Willer C. J., Schmidt E. M., Sengupta S., Peloso G. M., Gustafsson S., Kanoni S., Ganna A., Chen J., Buchkovich M. L., Mora S., et al. . 2013. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45: 1274–1283. - PMC - PubMed
    1. Surakka I., Horikoshi M., Mägi R., Sarin A-P., Mahajan A., Lagou V., Marullo L., Ferreira T., Miraglio B., and Timonen S.. 2015. The impact of low-frequency and rare variants on lipid levels. Nat. Genet. 47: 589–597. - PMC - PubMed

Publication types